Citation: Yao Chi, Tian Jia, Wang Hui, Zhang Dan-Wei, Liu Yi, Zhang Fan, Li Zhan-Ting. Loading-free supramolecular organic framework drug delivery systems (sof-DDSs) for doxorubicin: normal plasm and multidrug resistant cancer cell-adaptive delivery and release[J]. Chinese Chemical Letters, ;2017, 28(4): 893-899. doi: 10.1016/j.cclet.2017.01.005 shu

Loading-free supramolecular organic framework drug delivery systems (sof-DDSs) for doxorubicin: normal plasm and multidrug resistant cancer cell-adaptive delivery and release

Yao Chi ^a,1 ,
Tian Jia ^a,1 ,
Wang Hui ^a ,
Zhang Dan-Wei ^a ,
Liu Yi ^b,, ,
Zhang Fan ^a,, ,
Li Zhan-Ting ^a,,

a.
Collaborative Innovation Center of Chemistry for Energy Materials (iChEM), Department of Chemistry, Fudan University, Shanghai 200433, China
b.
The Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley 94720, United States

Corresponding author: Liu Yi, yliu@lbl.gov Zhang Fan, zhang_fan@fudan.edu.cn Li Zhan-Ting, ztli@fudan.edu.cn

Received Date: 22 December 2016
Revised Date: 27 December 2016
Accepted Date: 28 December 2016
Available Online: 9 April 2017

Figures(7)

Four water-soluble porous supramolecular organic framework drug delivery systems (sof-DDSs) have been used to adsorb doxorubicin (DOX) in water at physiological pH of 7.4, which is driven exclusively by hydrophobicity.The resulting complexes DOX@SOFs are formed instantaneously upon dissolving the components in water.The drug-adsorbed sof-DDSs can undergo plasm circulation with important maintenance of the drug and overcome the multidrug resistance of human breast MCF-7/Adr cancer cells. DOX is released readily in the cancer cells due to the protonation of its amino group in the acidic medium of cancer cells.In vitro and in vivo experiments reveal that the delivery of SOF-a-d remarkably improve the cytotoxicity of DOX for the MCF-7/Adr cells and tumors, leading to 13-19-fold reduction of the IC50 values as compared with that of DOX.This new sof-DDSs strategy omits the indispensable loading process required by most of reported nano-scaled carriers for neutral hydrophobic chemotherapeutic agents, and thus should be highly valuable for future development of low-cost delivery systems.
- Supramolecular organic framewor,
- Doxorubicin,
- Drug delivery,
- In situ preparation,
- Hydrophobicity,
- Human breast cancer,
- Controlled release
1. [1]
  (a) D. Ma, G. Hettiarachchi, D. Nguyen, et al. , Acyclic cucurbit[n] uril molecular containers enhance the solubility and bioactivity of poorly soluble pharma-ceuticals, Nature Chem. 4(2012)503-510;
  (b) R. Tong, L. Tang, L. Ma, et al. , Smart chemistry in polymeric nanomedicine, Chem. Soc. Rev. 43(2014)6982-7012;
  (c) Y. Cao, X. Y. Hu, Y. Li, et al. , Multistimuli-responsive supramolecular vesicles based on water-soluble pillar[6] arene and SAINTcomplexation for controllable drug release, J. Am. Chem. Soc. 136(2014)10762-10769;
  (d) Y. Zhou, H. Li, Y. W. Yang, Controlled drug delivery systems based on calixarenes, Chin. Chem. Lett. 26(2015)825-828;
  (e) Y. X. Wang, D. S. Guo, Y. C. Duan, Y. J. Wang, Y. Liu, Amphiphilic p-sulfonatocalix[4] arene asâ€œdrug chaperoneâ€for escorting anticancer, Drugs. Sci. Rep. 5(2015)9019;
  (f) Y. Z. Chen, Y. K. Huang, Y. Chen, et al. , Novel nanoparticles composed of chitosan and Î²-cyclodextrin derivatives as potential insoluble drug carrier, Chin. Chem. Lett. 26(2015)909-913;
  (g) T. Zhang, P. Huang, L. Shi, et al. , Self-assembled nanoparticles of amphiphilic twin drug from floxuridine and bendamustine for cancer therapy, Mol. Pharmaceutics 12(2015)2328-2336;
  (h) R. Jia, T. Wang, Q. Jiang, et al. , Self-assembled DNA nanostructures for drug delivery, Chin. J. Chem. 34(2016)265-272;
  (i) J. Sun, J. Wang, Z. Yang, Supramolecular assembly models of siRNA delivery systems, Chin. J. Chem. 33(2015)79-89;
  (j) Y. Wang, Y. Liu, Supramolecular assemblies based on p-sulfonatocalixarenes and their functions, Acta Chim. Sinica 73(2015)984-991;
  (k) C. Yao, P. Wang, X. Li, et al. , Near-infrared-triggered azobenzene-liposome/upconversion nanoparticle hybrid vesicles for remotely controlled drug delivery to overcome cancer multidrug resistance, Adv. Mater. 28(2016)9341-9348;
  (l) C. Wang, H. Zhang, D. Zeng, L. San, X. Mi, DNA nanotechnology mediated gold nanoparticle conjugates and their applications in biomedicine, Chin. J. Chem. 34(2016)299-307.
2. [2]
  (a) R. Tanbour, A. M. Martins, W. G. Pitt, G. A. Husseini, Drug delivery systems based on polymeric micelles and ultrasound: a review, Curr. Pharm. Design 22 (2016)2796-2807;
  (b) L. Zhao, J. Ding, C. Xiao, et al. , Poly (L-glutamic acid) microsphere: preparation and application in oral drug controlled release, Acta Chim. Sinica 73(2015)60-65;
  (c) T. M. Allen, P. R. Cullis, Liposomal drug delivery systems: from concept to clinical applications, Adv. Drug Deliv. Rev. 65(2013)36-48;
  (d) K. Wang, D. S. Guo, X. Wang, Y. Liu, Multistimuli responsive supramolecular vesicles based on the recognition of p-sulfonatocalixarene and its controllable release of doxorubicin, ACS Nano 5(2011)2880-2894.
3. [3]
  (a) H. Wang, Q. Huang, H. Chang, J. Xiao, Y. Cheng, Stimuli-responsive dendrimers in drug delivery, Biomater. Sci. 4(2016)375-390;
  (b) S. Zhang, J. Yang, M. Liu, et al. , Synthesis of peptide dendrimers and their application in the drug delivery system, Acta Chim. Sinica 74(2016)401-409;
  (c) Y. Zhou, W. Huang, J. Liu, X. Zhu, D. Yan, Self-assembly of hyperbranched polymers and its biomedical applications, Adv. Mater. 22(2010)4567-4590.
4. [4]
  (a) H. Q. Wu, C. C. Wang, Biodegradable smart nanogels: a new platform for targeting drug delivery and biomedical diagnostics, Langmuir 32(2016)6211-6225;
  (b) S. Liu, Y. Zhou, F. Chen, et al. , Rheological properties, drug release behavior and cytocompatibility of novel hydrogels prepared from carboxymethyl chitosan, Acta Chim. Sinica 73(2015)47-52.
5. [5]
  (a) M. Prato, K. Kostarelos, A. Bianco, Functionalized carbon nanotubes in drug design and discovery, Acc. Chem. Res. 41(2008)60-68;
  (b) F. Du, J. Xu, F. Zeng, S. Wu, Preparation of a multifunctional nano-carrier system based on carbon dots with pH-triggered drug release, Acta Chim. Sinica 74(2016)241-250.
6. [6]
  (a) I. Brigger, C. Dubernet, P. Couvreur, Nanoparticles in cancer therapy and diagnosis, Adv. Drug Deliv. Rev. 54(2002)631-651;
  (b) P. Yang, S. Gai, J. Lin, Functionalized mesoporous silica materials for controlled drug delivery, Chem. Soc. Rev. 41(2012)3679-3698;
  (c) T. Sun, Y. S. Zhang, B. Pang, et al. , Engineered nanoparticles for drug delivery in cancer therapy, Angew. Chem. Int. Ed. 53(2014)12320-12364;
  (d) P. Yang, L. Wang, H. Wang, Smart supramolecular nanosystems for bioimaging and drug delivery, Chin. J. Chem. 33(2015)59-70;
  (e) H. Liang, H. Tian, M. Deng, X. Chen, Gold nanoparticles for cancer theranostics, Chin. J. Chem. 33(2015)1001-1010;
  (f) Y. J. Chang, X. Z. Liu, Q. Zhao, et al. , P (VPBA-DMAEA) as a pH-sensitive nanovalve for mesoporous silica nanoparticles based controlled release, Chin. Chem. Lett. 26(2015)1203-1208;
  (g) X. Wang, L. Tan, Y. Yang, Controlled drug release systems based on mesoporous silica capped by gold nanoparticles, Acta Chim. Sinica 74(2016) 303-311;
  (h) Z. Tang, C. He, H. Tian, et al. , Polymeric nanostructured materials for biomedical applications, Progr. Polym. Sci. 60(2016)86-128.
7. [7]
  (a) J. Nicolas, Drug-initiated synthesis of polymer prodrugs: combining simplicity and efficacy in drug delivery, Chem. Mater. 28(2016)1591-1606;
  (b) Z. Du, Y. Zhang, J. Ye, H. Xu, M. Lang, Synthesis and properties of the poly (ε-caprolactone)-paclitaxel prodrug, Acta Chim. Sinica 73(2015)349-356.
8. [8]
  (a) D. Landesman-Milo, D. Peer, Transforming nanomedicines from lab scale production to novel clinical modality, Bioconjugate Chem 27(2016)855-862;
  (b) T. M. Allen, P. R. Cullis, Adv. Drug Deliv. Rev 65(2013)36-48.
9. [9]
  Cagnoni P.J., Walsh T.J., Prendergast M.M.. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients[J]. J.Clin.Oncol., 2000,18:2476-2483. doi: 10.1200/JCO.2000.18.12.2476
10. [10]
  (a) M. Kanamala, W. R. Wilson, M. Yang, B. D. Palmer, Z. Wu, Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review, Biomaterials 85(2016)152-167;
  (b) Y. Zhao, A. C. Tavares, M. A. Gauthier, Nano-engineered electro-responsive drug delivery systems, J. Mater. Chem. B 4(2016)3019-3030;
  (c) S. Ganta, H. Devalapally, A. Shahiwala, M. Amiji, A review of stimuli-responsive nanocarriers for drug and gene delivery, J. Controll. Release 126 (2008)187-204;
  (d) R. Cheng, F. Meng, C. Deng, H. A. Klok, Z. Zhong, Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery, Biomaterials 34(2013)3647-3657.
11. [11]
  (a) L. Brunsveld, B. J. B. Folmer, E. W. Meijer, R. P. Sijbesma, Supramolecular polymers, Chem. Rev. 101(2001)4071-4098;
  (b) L. Yang, X. Tan, Z. Wang, X. Zhang, Supramolecular polymers: historical development, preparation, characterization, and functions, Chem. Rev 115 (2015)7196-7239;
  (c) T. Aida, E. W. Meijer, S. I. Stupp, Functional supramolecular polymers, Science 335(2012)813-817;
  (d) X. Yan, F. Wang, B. Zheng, F. Huang, Stimuli-responsive supramolecular polymeric materials, Chem. Soc. Rev. 41(2012)6042-6065;
  (e) D. S. Guo, Y. Liu, Calixarene-based supramolecular polymerization in solution, Chem. Soc. Rev. 41(2012)5907-5921;
  (f) S. L. Li, T. Xiao, C. Lin, L. Wang, Advanced supramolecular polymers constructed by orthogonal self-assembly, Chem. Soc. Rev. 41(2012)5950-5968;
  (g) X. Ma, H. Tian, Stimuli-responsive supramolecular polymers in aqueous solution, Acc. Chem. Res. 47(2014)1971-1981;
  (h) E. A. Appel, J. del Barrio, X. J. Loh, O. A. Scherman, Supramolecular polymeric hydrogels, Chem. Soc. Rev 41(2012)6195-6214.
12. [12]
  (a) J. Tian, L. Chen, D. W. Zhang, Y. Liu, Z. T. Li, Supramolecular organic frameworks: engineering periodicity in water through host-guest chemistry, Chem. Commun. 52(2016)6351-6362;
  (b) H. Wang, D. W. Wang, Z. T. Li, Supramolecular organic frameworks (SOFs): water-phase periodic porous self-assembled architectures, Acta Chim. Sinica 73(2015)471-479;
  (c) T. Wan, T. Li, From supramolecular polymers to supramolecular organic frameworks: Engineering the periodicity of solution-phase self-assembled architectures, Imaging Sci. Photochem. 33(2015)3-14;
  (d) L. Chen, Y. C. Zhang, W. K. Wang, et al. , Conjugated radical cation dimerization-driven generation of supramolecular architectures, Chin. Chem. Lett. 26(2015)811-816.
13. [13]
  (a) K. D. Zhang, J. Tian, D. Hanifi, et al. , Toward a single-layer two-dimensional honeycomb supramolecular organic framework in water, J. Am. Chem. Soc. 135 (2013)17913-17918;
  (b) J. Tian, T. Y. Zhou, S. C. Zhang, et al. , Three-dimensional periodic supramolecular organic framework ion sponge in water and microcrystals, Nat, Commun. 5(2014)5574;
  (c) J. Tian, Z. Y. Xu, D. W. Zhang, et al. , Supramolecular metal-organic frameworks that display high homogeneous and heterogeneous photo-catalytic activity for H2 production, Nat. Commun. 7(2016)11580.
14. [14]
  Pfeffermann M., Dong R., Graf R.. Free-standing monolayer two-dimensional supramolecular organic framework with good internal order[J]. J. Am.Chem.Soc., 2015,137:14525-14532. doi: 10.1021/jacs.5b09638
15. [15]
  (a) Y. Zhang, T. G. Zhan, T. Y. Zhou, et al. , Fluorescence enhancement through the formation of a single-layer two-dimensional supramolecular organic frame-work and its application in highly selective recognition of picric acid, Chem. Commun. 52(2016)7588-7591;
  (b) S. Q. Xu, X. Zhang, C. B. Nie, et al. , The construction of a two-dimensional supramolecular organic framework with parallelogram pores and stepwise fluorescence enhancement, Chem. Commun. 51(2015)16417-16420.
16. [16]
  Tian J., Yao C., Yang W.L.. In situ-prepared homogeneous supramolecular organic framework drug delivery systems (sof-DDSs):overcoming cancer multidrug resistance and controlled release[J]. Chin.Chem.Lett., 2017,28:798-806. doi: 10.1016/j.cclet.2017.01.010
17. [17]
  Data from U. S. Food&Drug Administration: https: //www. cancer. gov/about-cancer/treatment/drugs.
18. [18]
  (a) Y. Barenholz, Doxil^®-The first FDA-approved nano-drug: Lessons learned, J. Control. Release 160(2012)117-134;
  (b) F. Meng, Y. Zhong, R. Cheng, C. Deng, Z. Zhong, pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances, Nanomedicine 9(2014)487-499. C. Yao et al. /Chinese Chemica
19. [19]
  Accelrys Materials Studio Release Notes, Release 5. 0, Accelrys Software Inc. , San Diego, 2008.
20. [20]
  (a) J. Fang, H. Nakamura, H. Maeda, The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect, Adv. Drug Deliv. Rev. 63(2011)136-151.
1. [1]
  Xingqun Pu , Rongrong Liu , Yuting Xie , Chenjing Yang , Jingyi Chen , Baoling Guo , Chun-Xia Zhao , Peng Zhao , Jian Ruan , Fangfu Ye , David A Weitz , Dong Chen . One-step preparation of biocompatible amphiphilic dimer nanoparticles with tunable particle morphology and surface property for interface stabilization and drug delivery. Chinese Chemical Letters, 2025, 36(3): 109820-. doi: 10.1016/j.cclet.2024.109820
2. [2]
  Tong Tong , Lezong Chen , Siying Wu , Zhong Cao , Yuanbin Song , Jun Wu . Establishment of a leucine-based poly(ester amide)s library with self-anticancer effect as nano-drug carrier for colorectal cancer treatment. Chinese Chemical Letters, 2024, 35(12): 109689-. doi: 10.1016/j.cclet.2024.109689
3. [3]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
4. [4]
  Xiangqian Cao , Chenkai Yang , Xiaodong Zhu , Mengxin Zhao , Yilin Yan , Zhengnan Huang , Jinming Cai , Jingming Zhuang , Shengzhou Li , Wei Li , Bing Shen . Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM. Chinese Chemical Letters, 2024, 35(8): 109199-. doi: 10.1016/j.cclet.2023.109199
5. [5]
  Jiaxu Wang , Jinxie Zhang , Xiuping Wang , Jingying Wang , Lina Chen , Jiahui Cao , Wei Cao , Siyu Liang , Ping Luan , Ke Zheng , Xiao-Kun Ouyang , Li Gao , Xiaowen Ou , Fan Zhang , Meitong Ou , Lin Mei . CaCO₃-coated hollow mesoporous silica nanoparticles for pH-responsive fungicides release. Chinese Chemical Letters, 2024, 35(12): 109697-. doi: 10.1016/j.cclet.2024.109697
6. [6]
  Zhilong Xie , Guohui Zhang , Ya Meng , Yefei Tong , Jian Deng , Honghui Li , Qingqing Ma , Shisong Han , Wenjun Ni . A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein. Chinese Chemical Letters, 2024, 35(11): 109584-. doi: 10.1016/j.cclet.2024.109584
7. [7]
  Yuanzheng Wang , Chen Zhang , Shuyan Han , Xiaoli Kong , Changyun Quan , Jun Wu , Wei Zhang . Cancer cell membrane camouflaged biomimetic gelatin-based nanogel for tumor inhibition. Chinese Chemical Letters, 2024, 35(11): 109578-. doi: 10.1016/j.cclet.2024.109578
8. [8]
  Makhloufi Zoulikha , Zhongjian Chen , Jun Wu , Wei He . Approved delivery strategies for biopharmaceuticals. Chinese Chemical Letters, 2025, 36(2): 110225-. doi: 10.1016/j.cclet.2024.110225
9. [9]
  Zixu Xie , Pengfei Zhang , Ziyao Zhang , Chen Chen , Xing Wang . The choice of antimicrobial polymers: Hydrophilic or hydrophobic?. Chinese Chemical Letters, 2024, 35(9): 109768-. doi: 10.1016/j.cclet.2024.109768
10. [10]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420
11. [11]
  Jiaqi Huang , Renjiang Kong , Yanmei Li , Ni Yan , Yeyang Wu , Ziwen Qiu , Zhenming Lu , Xiaona Rao , Shiying Li , Hong Cheng . Feedback enhanced tumor targeting delivery of albumin-based nanomedicine to amplify photodynamic therapy by regulating AMPK signaling and inhibiting GSTs. Chinese Chemical Letters, 2024, 35(8): 109254-. doi: 10.1016/j.cclet.2023.109254
12. [12]
  Jiangshan Xu , Weifei Zhang , Zhengwen Cai , Yong Li , Long Bai , Shaojingya Gao , Qiang Sun , Yunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620
13. [13]
  Shuheng Zhang , Yuanyuan Zhang , Wanyu Wang , Yuzhu Hu , Xinchuan Chen , Bilan Wang , Xiang Gao . A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy. Chinese Chemical Letters, 2024, 35(12): 109658-. doi: 10.1016/j.cclet.2024.109658
14. [14]
  Lihang Wang , Mary Li Javier , Chunshan Luo , Tingsheng Lu , Shudan Yao , Bing Qiu , Yun Wang , Yunfeng Lin . Research advances of tetrahedral framework nucleic acid-based systems in biomedicine. Chinese Chemical Letters, 2024, 35(11): 109591-. doi: 10.1016/j.cclet.2024.109591
15. [15]
  Yong-Dan Zhao , Yidan Wang , Rongrong Wang , Lina Chen , Hengtong Zuo , Xi Wang , Jihong Qiang , Geng Wang , Qingxia Li , Canqi Ping , Shuqiu Zhang , Hao Wang . Reversing artemisinin resistance by leveraging thermo-responsive nanoplatform to downregulating GSH. Chinese Chemical Letters, 2024, 35(6): 108929-. doi: 10.1016/j.cclet.2023.108929
16. [16]
  Keyang Li , Yanan Wang , Yatao Xu , Guohua Shi , Sixian Wei , Xue Zhang , Baomei Zhang , Qiang Jia , Huanhua Xu , Liangmin Yu , Jun Wu , Zhiyu He . Flash nanocomplexation (FNC): A new microvolume mixing method for nanomedicine formulation. Chinese Chemical Letters, 2024, 35(10): 109511-. doi: 10.1016/j.cclet.2024.109511
17. [17]
  Yinglan Yu , Sajid Hussain , Jianping Qi , Lei Luo , Xuemei Zhang . Mechanisms and applications: Cargos transport to basolateral membranes in polarized epithelial cells. Chinese Chemical Letters, 2024, 35(12): 109673-. doi: 10.1016/j.cclet.2024.109673
18. [18]
  Han Wu , Yumei Wang , Zekai Ren , Hailin Cong , Youqing Shen , Bing Yu . The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy. Chinese Chemical Letters, 2025, 36(4): 109996-. doi: 10.1016/j.cclet.2024.109996
19. [19]
  Yuequan Wang , Congtian Wu , Chengcheng Feng , Qin Chen , Zhonggui He , Shenwu Zhang , Cong Luo , Jin Sun . Spatiotemporally-controlled supramolecular hybrid nanoassembly enabling ferroptosis-augmented photodynamic immunotherapy of cancer. Chinese Chemical Letters, 2025, 36(3): 109902-. doi: 10.1016/j.cclet.2024.109902
20. [20]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335

Get Citation

PDF

XML

Metrics

PDF Downloads(1)
Abstract views(704)
HTML views(31)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142